Nuprobe

NuProbe takes a multi-platform approach to apply its breakthrough technologies in genomics research to enable diseases to be detected, treated, and cured at early stages for better outcomes with lower costs. Founded in 2016 and building on scientific findings licensed from the Wyss Institute at Harvard and Rice University, NuProbe is a privately held company with facilities in the US (Houston, TX) and China (Shanghai). The company has assembled an executive team of industry veterans, world-renowned scientists, and entrepreneurs.